ATPAF1 Inhibitors

Chemical inhibitors of ATP synthase assembly factor 1 (ATPAF1) function primarily by disrupting the processes and components ATPAF1 facilitates and interacts with, rather than directly binding to or altering ATPAF1 itself. Oligomycin A, Venturicidin A, Aurovertin B, Efrapeptin, Resveratrol, and Bedaquiline operate by targeting ATP synthase, the molecular machine that ATPAF1 helps assemble and maintain. Oligomycin A and Venturicidin A obstruct the proton channel within ATP synthase, a critical component for the synthesis of ATP. Aurovertin B and Efrapeptin prevent ATP synthase from undergoing necessary conformational changes, directly impacting ATP generation. Resveratrol binds to the F1 subunit of ATP synthase, leading to inhibition. Bedaquiline, while specific to mycobacteria, similarly inhibits ATP synthase's proton pump, demonstrating a commonality in the disruption of proton gradients that are essential for ATP synthase function, thus indirectly reducing the need for ATPAF1's role in the assembly of this enzyme.

Further indirect inhibition of ATPAF1 occurs through the actions of chemical inhibitors like Rotenone, Piericidin A, Tetrachlorohydroquinone, and Carboxin, which all target the mitochondrial electron transport chain (ETC), albeit at different points. Rotenone and Piericidin A impair complex I of the ETC, leading to a reduced proton gradient and therefore diminished ATP synthase activity. Tetrachlorohydroquinone disrupts the ETC more broadly, while Carboxin specifically inhibits succinate dehydrogenase, another component of the ETC. The resulting decrease in electron flow and proton gradient compromises the efficiency of ATP synthesis and, consequently, the assembly function of ATPAF1. Finally, Terpestacin targets prohibitin, a protein involved in mitochondrial assembly and function, which can also affect the proper functioning and assembly of ATP synthase, thereby implicating ATPAF1 indirectly. Each of these chemicals, by inhibiting different aspects of ATP synthesis, highlight the dependency of ATPAF1's function on the integrity and activity of the mitochondrial ATP synthesis machinery.